instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'FORMOTEROL FUMARATE DIHYDRATE'? | Premature atrial contractions with multiple patterns of aberrant conduction followed by torsade de pointes in a patient with polymyalgia rheumatica: A case report.
BACKGROUND
Recent studies have shown that QT interval prolongation is associated with disease severity and predicts mortality in systemic inflammatory disea... | Respiratory (inhalation) | DrugAdministrationRoute | CC BY | 34664888 | 20,333,770 | 2021-09-17 |
What was the administration route of drug 'NIFEKALANT HYDROCHLORIDE'? | Premature atrial contractions with multiple patterns of aberrant conduction followed by torsade de pointes in a patient with polymyalgia rheumatica: A case report.
BACKGROUND
Recent studies have shown that QT interval prolongation is associated with disease severity and predicts mortality in systemic inflammatory disea... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34664888 | 20,333,770 | 2021-09-17 |
What was the administration route of drug 'VALSARTAN'? | Premature atrial contractions with multiple patterns of aberrant conduction followed by torsade de pointes in a patient with polymyalgia rheumatica: A case report.
BACKGROUND
Recent studies have shown that QT interval prolongation is associated with disease severity and predicts mortality in systemic inflammatory disea... | Oral | DrugAdministrationRoute | CC BY | 34664888 | 20,333,770 | 2021-09-17 |
What was the dosage of drug 'FORMOTEROL FUMARATE DIHYDRATE'? | Premature atrial contractions with multiple patterns of aberrant conduction followed by torsade de pointes in a patient with polymyalgia rheumatica: A case report.
BACKGROUND
Recent studies have shown that QT interval prolongation is associated with disease severity and predicts mortality in systemic inflammatory disea... | 2 PUFFS PER DAY | DrugDosageText | CC BY | 34664888 | 20,333,770 | 2021-09-17 |
What was the outcome of reaction 'Circulatory collapse'? | Premature atrial contractions with multiple patterns of aberrant conduction followed by torsade de pointes in a patient with polymyalgia rheumatica: A case report.
BACKGROUND
Recent studies have shown that QT interval prolongation is associated with disease severity and predicts mortality in systemic inflammatory disea... | Recovered | ReactionOutcome | CC BY | 34664888 | 20,333,770 | 2021-09-17 |
What was the outcome of reaction 'Ventricular tachyarrhythmia'? | Premature atrial contractions with multiple patterns of aberrant conduction followed by torsade de pointes in a patient with polymyalgia rheumatica: A case report.
BACKGROUND
Recent studies have shown that QT interval prolongation is associated with disease severity and predicts mortality in systemic inflammatory disea... | Recovered | ReactionOutcome | CC BY | 34664888 | 20,333,770 | 2021-09-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal infection'. | The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma.
Relatively little data are available on how the response to the coronavirus disease 2019 (COVID-19) pandemic has affected treatment outcomes in patients receiving chemotherapy for lymphom... | BORTEZOMIB, CARFILZOMIB, POMALIDOMIDE | DrugsGivenReaction | CC BY-NC | 34666434 | 20,279,324 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aspergillus infection'. | The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma.
Relatively little data are available on how the response to the coronavirus disease 2019 (COVID-19) pandemic has affected treatment outcomes in patients receiving chemotherapy for lymphom... | BORTEZOMIB, CARFILZOMIB, LENALIDOMIDE, POMALIDOMIDE, THALIDOMIDE | DrugsGivenReaction | CC BY-NC | 34666434 | 20,297,764 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma.
Relatively little data are available on how the response to the coronavirus disease 2019 (COVID-19) pandemic has affected treatment outcomes in patients receiving chemotherapy for lymphom... | BORTEZOMIB, CARFILZOMIB, POMALIDOMIDE | DrugsGivenReaction | CC BY-NC | 34666434 | 20,279,324 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma.
Relatively little data are available on how the response to the coronavirus disease 2019 (COVID-19) pandemic has affected treatment outcomes in patients receiving chemotherapy for lymphom... | BORTEZOMIB, CARFILZOMIB, LENALIDOMIDE, POMALIDOMIDE, THALIDOMIDE | DrugsGivenReaction | CC BY-NC | 34666434 | 20,297,764 | 2021-11 |
What was the outcome of reaction 'Abdominal infection'? | The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma.
Relatively little data are available on how the response to the coronavirus disease 2019 (COVID-19) pandemic has affected treatment outcomes in patients receiving chemotherapy for lymphom... | Fatal | ReactionOutcome | CC BY-NC | 34666434 | 20,279,324 | 2021-11 |
What was the outcome of reaction 'Plasma cell myeloma'? | The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma.
Relatively little data are available on how the response to the coronavirus disease 2019 (COVID-19) pandemic has affected treatment outcomes in patients receiving chemotherapy for lymphom... | Fatal | ReactionOutcome | CC BY-NC | 34666434 | 20,279,324 | 2021-11 |
What was the outcome of reaction 'Pneumonia'? | The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma.
Relatively little data are available on how the response to the coronavirus disease 2019 (COVID-19) pandemic has affected treatment outcomes in patients receiving chemotherapy for lymphom... | Fatal | ReactionOutcome | CC BY-NC | 34666434 | 20,297,764 | 2021-11 |
What was the outcome of reaction 'Urinary tract infection'? | The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma.
Relatively little data are available on how the response to the coronavirus disease 2019 (COVID-19) pandemic has affected treatment outcomes in patients receiving chemotherapy for lymphom... | Fatal | ReactionOutcome | CC BY-NC | 34666434 | 20,297,764 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Mycobacteria avium-related peritonitis in a patient undergoing peritoneal dialysis: case report and review of the literature.
BACKGROUND
Mycobacteria avium (M. avium) is a species of ubiquitous slowly growing nontuberculous mycobacteria. It causes opportunistic infections. However, M. avium-related peritonitis in perit... | CEFOPERAZONE, LEVOFLOXACIN, LINEZOLID, MEROPENEM | DrugsGivenReaction | CC BY | 34666716 | 20,453,559 | 2021-10-19 |
What was the outcome of reaction 'Drug ineffective'? | Mycobacteria avium-related peritonitis in a patient undergoing peritoneal dialysis: case report and review of the literature.
BACKGROUND
Mycobacteria avium (M. avium) is a species of ubiquitous slowly growing nontuberculous mycobacteria. It causes opportunistic infections. However, M. avium-related peritonitis in perit... | Fatal | ReactionOutcome | CC BY | 34666716 | 20,453,559 | 2021-10-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Conductive deafness'. | Clinical and event-based outcomes of patients with mucopolysaccharidosis VI receiving enzyme replacement therapy in Turkey: a case series.
The objective of this study was to describe clinical manifestations and events of patients with mucopolysaccharidosis (MPS) VI in Turkey who are treated with galsulfase enzyme repla... | GALSULFASE | DrugsGivenReaction | CC BY | 34666789 | 20,005,175 | 2021-10-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Corneal opacity'. | Clinical and event-based outcomes of patients with mucopolysaccharidosis VI receiving enzyme replacement therapy in Turkey: a case series.
The objective of this study was to describe clinical manifestations and events of patients with mucopolysaccharidosis (MPS) VI in Turkey who are treated with galsulfase enzyme repla... | GALSULFASE | DrugsGivenReaction | CC BY | 34666789 | 20,005,175 | 2021-10-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Magnetic resonance imaging head abnormal'. | Clinical and event-based outcomes of patients with mucopolysaccharidosis VI receiving enzyme replacement therapy in Turkey: a case series.
The objective of this study was to describe clinical manifestations and events of patients with mucopolysaccharidosis (MPS) VI in Turkey who are treated with galsulfase enzyme repla... | GALSULFASE | DrugsGivenReaction | CC BY | 34666789 | 20,005,175 | 2021-10-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Spinal disorder'. | Clinical and event-based outcomes of patients with mucopolysaccharidosis VI receiving enzyme replacement therapy in Turkey: a case series.
The objective of this study was to describe clinical manifestations and events of patients with mucopolysaccharidosis (MPS) VI in Turkey who are treated with galsulfase enzyme repla... | GALSULFASE | DrugsGivenReaction | CC BY | 34666789 | 20,005,175 | 2021-10-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Autoimmune epilepsy due to N-methyl-D-aspartate receptor antibodies in a child: a case report.
BACKGROUND
Seizures of autoimmune etiology may occur independent of or predate syndromes of encephalitis. We report a child with "pure" autoimmune epilepsy followed up for 7 years to highlight long-term effects of this epilep... | CARBAMAZEPINE, CLOBAZAM, LEVETIRACETAM, PHENOBARBITAL | DrugsGivenReaction | CC BY | 34666812 | 20,178,944 | 2021-10-20 |
What was the administration route of drug 'CARBAMAZEPINE'? | Autoimmune epilepsy due to N-methyl-D-aspartate receptor antibodies in a child: a case report.
BACKGROUND
Seizures of autoimmune etiology may occur independent of or predate syndromes of encephalitis. We report a child with "pure" autoimmune epilepsy followed up for 7 years to highlight long-term effects of this epilep... | Oral | DrugAdministrationRoute | CC BY | 34666812 | 20,178,944 | 2021-10-20 |
What was the administration route of drug 'CLOBAZAM'? | Autoimmune epilepsy due to N-methyl-D-aspartate receptor antibodies in a child: a case report.
BACKGROUND
Seizures of autoimmune etiology may occur independent of or predate syndromes of encephalitis. We report a child with "pure" autoimmune epilepsy followed up for 7 years to highlight long-term effects of this epilep... | Oral | DrugAdministrationRoute | CC BY | 34666812 | 20,178,944 | 2021-10-20 |
What was the administration route of drug 'LEVETIRACETAM'? | Autoimmune epilepsy due to N-methyl-D-aspartate receptor antibodies in a child: a case report.
BACKGROUND
Seizures of autoimmune etiology may occur independent of or predate syndromes of encephalitis. We report a child with "pure" autoimmune epilepsy followed up for 7 years to highlight long-term effects of this epilep... | Oral | DrugAdministrationRoute | CC BY | 34666812 | 20,178,944 | 2021-10-20 |
What was the administration route of drug 'PHENOBARBITAL'? | Autoimmune epilepsy due to N-methyl-D-aspartate receptor antibodies in a child: a case report.
BACKGROUND
Seizures of autoimmune etiology may occur independent of or predate syndromes of encephalitis. We report a child with "pure" autoimmune epilepsy followed up for 7 years to highlight long-term effects of this epilep... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34666812 | 20,178,944 | 2021-10-20 |
What was the dosage of drug 'PHENOBARBITAL'? | Autoimmune epilepsy due to N-methyl-D-aspartate receptor antibodies in a child: a case report.
BACKGROUND
Seizures of autoimmune etiology may occur independent of or predate syndromes of encephalitis. We report a child with "pure" autoimmune epilepsy followed up for 7 years to highlight long-term effects of this epilep... | 20 MILLIGRAM/KILOGRAM | DrugDosageText | CC BY | 34666812 | 20,178,944 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancreatic carcinoma metastatic'. | Potential benefit of treatment with MEK inhibitors and chemotherapy in BRAF-mutated KRAS wild-type pancreatic ductal adenocarcinoma patients: a case report.
This is the first case report of a 60-yr-old female who underwent therapy for metastatic pancreatic cancer with fluorouracil, leucovorin, irinotecan, and oxaliplat... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 34667063 | 20,190,490 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Potential benefit of treatment with MEK inhibitors and chemotherapy in BRAF-mutated KRAS wild-type pancreatic ductal adenocarcinoma patients: a case report.
This is the first case report of a 60-yr-old female who underwent therapy for metastatic pancreatic cancer with fluorouracil, leucovorin, irinotecan, and oxaliplat... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 34667063 | 20,190,490 | 2021-10 |
What was the outcome of reaction 'Pancreatic carcinoma metastatic'? | Potential benefit of treatment with MEK inhibitors and chemotherapy in BRAF-mutated KRAS wild-type pancreatic ductal adenocarcinoma patients: a case report.
This is the first case report of a 60-yr-old female who underwent therapy for metastatic pancreatic cancer with fluorouracil, leucovorin, irinotecan, and oxaliplat... | Recovering | ReactionOutcome | CC BY-NC | 34667063 | 20,190,490 | 2021-10 |
What was the outcome of reaction 'Product use in unapproved indication'? | Potential benefit of treatment with MEK inhibitors and chemotherapy in BRAF-mutated KRAS wild-type pancreatic ductal adenocarcinoma patients: a case report.
This is the first case report of a 60-yr-old female who underwent therapy for metastatic pancreatic cancer with fluorouracil, leucovorin, irinotecan, and oxaliplat... | Recovered | ReactionOutcome | CC BY-NC | 34667063 | 20,190,490 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colitis'. | Clinical outcomes and longitudinal circulating tumor DNA changes after treatment with nivolumab and olaparib in immunotherapy relapsed melanoma with detected homologous recombination deficiency.
The treatment of immunotherapy relapsed cutaneous melanoma constitutes a challenge in both research and clinical practice fie... | IPILIMUMAB | DrugsGivenReaction | CC BY-NC | 34667064 | 20,154,203 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated hepatitis'. | Clinical outcomes and longitudinal circulating tumor DNA changes after treatment with nivolumab and olaparib in immunotherapy relapsed melanoma with detected homologous recombination deficiency.
The treatment of immunotherapy relapsed cutaneous melanoma constitutes a challenge in both research and clinical practice fie... | NIVOLUMAB, OLAPARIB | DrugsGivenReaction | CC BY-NC | 34667064 | 20,152,765 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product use issue'. | Clinical outcomes and longitudinal circulating tumor DNA changes after treatment with nivolumab and olaparib in immunotherapy relapsed melanoma with detected homologous recombination deficiency.
The treatment of immunotherapy relapsed cutaneous melanoma constitutes a challenge in both research and clinical practice fie... | NIVOLUMAB, OLAPARIB | DrugsGivenReaction | CC BY-NC | 34667064 | 20,152,765 | 2021-10 |
What was the administration route of drug 'NIVOLUMAB'? | Clinical outcomes and longitudinal circulating tumor DNA changes after treatment with nivolumab and olaparib in immunotherapy relapsed melanoma with detected homologous recombination deficiency.
The treatment of immunotherapy relapsed cutaneous melanoma constitutes a challenge in both research and clinical practice fie... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34667064 | 20,152,765 | 2021-10 |
What was the administration route of drug 'OLAPARIB'? | Clinical outcomes and longitudinal circulating tumor DNA changes after treatment with nivolumab and olaparib in immunotherapy relapsed melanoma with detected homologous recombination deficiency.
The treatment of immunotherapy relapsed cutaneous melanoma constitutes a challenge in both research and clinical practice fie... | Oral | DrugAdministrationRoute | CC BY-NC | 34667064 | 20,152,765 | 2021-10 |
What was the outcome of reaction 'Immune-mediated hepatitis'? | Clinical outcomes and longitudinal circulating tumor DNA changes after treatment with nivolumab and olaparib in immunotherapy relapsed melanoma with detected homologous recombination deficiency.
The treatment of immunotherapy relapsed cutaneous melanoma constitutes a challenge in both research and clinical practice fie... | Recovered | ReactionOutcome | CC BY-NC | 34667064 | 20,152,765 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bradycardia'. | Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine.
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia (EAT) in an infant presenting ... | ADENOSINE, AMIODARONE HYDROCHLORIDE, DIGOXIN, EPINEPHRINE, FUROSEMIDE, METOPROLOL TARTRATE, MILRINONE LACTATE, SOTALOL HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-SA | 34667421 | 20,108,109 | 2021 |
What is the weight of the patient? | Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine.
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia (EAT) in an infant presenting ... | 5 kg. | Weight | CC BY-NC-SA | 34667421 | 20,140,756 | 2021 |
What was the administration route of drug 'AMIODARONE'? | Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine.
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia (EAT) in an infant presenting ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-SA | 34667421 | 20,140,756 | 2021 |
What was the administration route of drug 'DIGOXIN'? | Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine.
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia (EAT) in an infant presenting ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-SA | 34667421 | 20,140,756 | 2021 |
What was the administration route of drug 'METOPROLOL TARTRATE'? | Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine.
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia (EAT) in an infant presenting ... | Intravenous bolus | DrugAdministrationRoute | CC BY-NC-SA | 34667421 | 20,108,109 | 2021 |
What was the administration route of drug 'METOPROLOL'? | Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine.
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia (EAT) in an infant presenting ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-SA | 34667421 | 20,140,756 | 2021 |
What was the administration route of drug 'MILRINONE'? | Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine.
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia (EAT) in an infant presenting ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-SA | 34667421 | 20,140,756 | 2021 |
What was the dosage of drug 'AMIODARONE'? | Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine.
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia (EAT) in an infant presenting ... | 15 MICROGRAM/KILOGRAM, QMINUTE | DrugDosageText | CC BY-NC-SA | 34667421 | 20,140,756 | 2021 |
What was the dosage of drug 'DIGOXIN'? | Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine.
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia (EAT) in an infant presenting ... | 15 UG/KG(OVER 30 MIN) | DrugDosageText | CC BY-NC-SA | 34667421 | 20,108,109 | 2021 |
What was the dosage of drug 'FUROSEMIDE'? | Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine.
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia (EAT) in an infant presenting ... | 1 MILLIGRAM/KILOGRAM, QD | DrugDosageText | CC BY-NC-SA | 34667421 | 20,140,756 | 2021 |
What was the dosage of drug 'METOPROLOL TARTRATE'? | Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine.
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia (EAT) in an infant presenting ... | UNK(INFUSION) | DrugDosageText | CC BY-NC-SA | 34667421 | 20,108,109 | 2021 |
What was the dosage of drug 'METOPROLOL'? | Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine.
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia (EAT) in an infant presenting ... | THREE DOSES OF BOLUS INTRAVENOUS METOPROLOL | DrugDosageText | CC BY-NC-SA | 34667421 | 20,140,756 | 2021 |
What was the dosage of drug 'MILRINONE LACTATE'? | Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine.
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia (EAT) in an infant presenting ... | UNK (0.5 MCG/KG/MIN)(INFUSION); | DrugDosageText | CC BY-NC-SA | 34667421 | 20,108,109 | 2021 |
What was the dosage of drug 'MILRINONE'? | Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine.
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia (EAT) in an infant presenting ... | 0.5 MICROGRAM/KILOGRAM, QMINUTE | DrugDosageText | CC BY-NC-SA | 34667421 | 20,140,756 | 2021 |
What was the dosage of drug 'SOTALOL HYDROCHLORIDE'? | Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine.
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia (EAT) in an infant presenting ... | 1 MG/KG | DrugDosageText | CC BY-NC-SA | 34667421 | 20,108,109 | 2021 |
What was the dosage of drug 'SOTALOL'? | Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine.
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia (EAT) in an infant presenting ... | 1 MILLIGRAM/KILOGRAM | DrugDosageText | CC BY-NC-SA | 34667421 | 20,140,756 | 2021 |
What was the outcome of reaction 'Bradycardia'? | Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradine.
This report describes two cases of tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia (EAT) in an infant presenting ... | Recovering | ReactionOutcome | CC BY-NC-SA | 34667421 | 20,108,109 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | COVID-19-Associated Severe Autoimmune Hemolytic Anemia: A Rare Case Report.
Autoimmune hemolytic anemia (AIHA) is a very rare presentation of COVID-19, and AIHA due to COVID-19 alone (i.e., in the absence of an associated underlying disorder) is extremely rare. Warm agglutinin disease accounts for the majority of AIHA ... | AZITHROMYCIN, METHYLPREDNISOLONE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-SA | 34667477 | 20,540,980 | 2021 |
What was the administration route of drug 'AZITHROMYCIN'? | COVID-19-Associated Severe Autoimmune Hemolytic Anemia: A Rare Case Report.
Autoimmune hemolytic anemia (AIHA) is a very rare presentation of COVID-19, and AIHA due to COVID-19 alone (i.e., in the absence of an associated underlying disorder) is extremely rare. Warm agglutinin disease accounts for the majority of AIHA ... | Oral | DrugAdministrationRoute | CC BY-NC-SA | 34667477 | 20,540,980 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | COVID-19-Associated Severe Autoimmune Hemolytic Anemia: A Rare Case Report.
Autoimmune hemolytic anemia (AIHA) is a very rare presentation of COVID-19, and AIHA due to COVID-19 alone (i.e., in the absence of an associated underlying disorder) is extremely rare. Warm agglutinin disease accounts for the majority of AIHA ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-SA | 34667477 | 20,540,980 | 2021 |
What was the administration route of drug 'PREDNISOLONE'? | COVID-19-Associated Severe Autoimmune Hemolytic Anemia: A Rare Case Report.
Autoimmune hemolytic anemia (AIHA) is a very rare presentation of COVID-19, and AIHA due to COVID-19 alone (i.e., in the absence of an associated underlying disorder) is extremely rare. Warm agglutinin disease accounts for the majority of AIHA ... | Oral | DrugAdministrationRoute | CC BY-NC-SA | 34667477 | 20,540,980 | 2021 |
What was the dosage of drug 'AZITHROMYCIN'? | COVID-19-Associated Severe Autoimmune Hemolytic Anemia: A Rare Case Report.
Autoimmune hemolytic anemia (AIHA) is a very rare presentation of COVID-19, and AIHA due to COVID-19 alone (i.e., in the absence of an associated underlying disorder) is extremely rare. Warm agglutinin disease accounts for the majority of AIHA ... | 500 MG, QD | DrugDosageText | CC BY-NC-SA | 34667477 | 20,540,980 | 2021 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | COVID-19-Associated Severe Autoimmune Hemolytic Anemia: A Rare Case Report.
Autoimmune hemolytic anemia (AIHA) is a very rare presentation of COVID-19, and AIHA due to COVID-19 alone (i.e., in the absence of an associated underlying disorder) is extremely rare. Warm agglutinin disease accounts for the majority of AIHA ... | 1 GRAM, QD | DrugDosageText | CC BY-NC-SA | 34667477 | 20,540,980 | 2021 |
What was the dosage of drug 'PREDNISOLONE'? | COVID-19-Associated Severe Autoimmune Hemolytic Anemia: A Rare Case Report.
Autoimmune hemolytic anemia (AIHA) is a very rare presentation of COVID-19, and AIHA due to COVID-19 alone (i.e., in the absence of an associated underlying disorder) is extremely rare. Warm agglutinin disease accounts for the majority of AIHA ... | 1 MILLIGRAM/KILOGRAM, QD | DrugDosageText | CC BY-NC-SA | 34667477 | 20,540,980 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34667538 | 20,078,637 | 2021-09-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Basal cell carcinoma'. | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34667538 | 20,078,637 | 2021-09-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epistaxis'. | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34667538 | 20,078,637 | 2021-09-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematuria'. | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34667538 | 20,078,637 | 2021-09-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage'. | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34667538 | 20,022,848 | 2021-09-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperhomocysteinaemia'. | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34667538 | 20,078,637 | 2021-09-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypertensive heart disease'. | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34667538 | 20,078,637 | 2021-09-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Melaena'. | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34667538 | 20,078,637 | 2021-09-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocardial ischaemia'. | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34667538 | 20,078,637 | 2021-09-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Transitional cell carcinoma'. | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC | 34667538 | 20,078,637 | 2021-09-06 |
What is the weight of the patient? | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | 67 kg. | Weight | CC BY-NC | 34667538 | 20,058,803 | 2021-09-06 |
What was the outcome of reaction 'Anaemia'? | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | Recovered | ReactionOutcome | CC BY-NC | 34667538 | 20,022,848 | 2021-09-06 |
What was the outcome of reaction 'Basal cell carcinoma'? | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | Recovered | ReactionOutcome | CC BY-NC | 34667538 | 20,078,637 | 2021-09-06 |
What was the outcome of reaction 'Epistaxis'? | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | Recovered | ReactionOutcome | CC BY-NC | 34667538 | 20,078,637 | 2021-09-06 |
What was the outcome of reaction 'Haematuria'? | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | Recovered | ReactionOutcome | CC BY-NC | 34667538 | 20,078,637 | 2021-09-06 |
What was the outcome of reaction 'Haemorrhage'? | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | Recovered | ReactionOutcome | CC BY-NC | 34667538 | 20,022,848 | 2021-09-06 |
What was the outcome of reaction 'Hypertensive heart disease'? | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | Recovered | ReactionOutcome | CC BY-NC | 34667538 | 20,078,637 | 2021-09-06 |
What was the outcome of reaction 'Melaena'? | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | Recovered | ReactionOutcome | CC BY-NC | 34667538 | 20,022,848 | 2021-09-06 |
What was the outcome of reaction 'Myocardial ischaemia'? | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | Recovered | ReactionOutcome | CC BY-NC | 34667538 | 20,078,637 | 2021-09-06 |
What was the outcome of reaction 'Transitional cell carcinoma'? | Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease.
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbid... | Recovered | ReactionOutcome | CC BY-NC | 34667538 | 20,078,637 | 2021-09-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pericarditis'. | Cardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis.
Checkpoint inhibitors are novel and promising anticancer agents. However, acute pericarditis is the second most common chemotherapy-associated cardiotoxicity and associated with high mortality up to 21%. Cardiac MRI offers a one-stop-shop cardiac analy... | PEMBROLIZUMAB, PEMETREXED | DrugsGivenReaction | CC BY | 34667605 | 20,333,688 | 2021-10 |
What was the outcome of reaction 'Pericarditis'? | Cardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis.
Checkpoint inhibitors are novel and promising anticancer agents. However, acute pericarditis is the second most common chemotherapy-associated cardiotoxicity and associated with high mortality up to 21%. Cardiac MRI offers a one-stop-shop cardiac analy... | Recovering | ReactionOutcome | CC BY | 34667605 | 20,333,688 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Endocarditis'. | Endovascular Coil Embolization of Superior Mesenteric Artery Branch Pseudoaneurysm.
Visceral artery pseudoaneurysms are rare but potentially life-threatening. Among visceral artery pseudoaneurysm (VAPA), the superior mesenteric artery (SMA) pseudoaneurysm is the rarest type. VAPAs are usually related with infection, in... | APIXABAN | DrugsGivenReaction | CC BY | 34667689 | 20,027,254 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vascular pseudoaneurysm'. | Endovascular Coil Embolization of Superior Mesenteric Artery Branch Pseudoaneurysm.
Visceral artery pseudoaneurysms are rare but potentially life-threatening. Among visceral artery pseudoaneurysm (VAPA), the superior mesenteric artery (SMA) pseudoaneurysm is the rarest type. VAPAs are usually related with infection, in... | APIXABAN | DrugsGivenReaction | CC BY | 34667689 | 20,027,254 | 2021-09 |
What was the outcome of reaction 'Vascular pseudoaneurysm'? | Endovascular Coil Embolization of Superior Mesenteric Artery Branch Pseudoaneurysm.
Visceral artery pseudoaneurysms are rare but potentially life-threatening. Among visceral artery pseudoaneurysm (VAPA), the superior mesenteric artery (SMA) pseudoaneurysm is the rarest type. VAPAs are usually related with infection, in... | Recovered | ReactionOutcome | CC BY | 34667689 | 20,027,254 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaphylactic reaction'. | Tropicamide and anaphylaxis: A case report.
A 6-month-old boy was brought to the ophthalmology outpatient clinic of our hospital by his parents with the suspicion of esotropia of his left eye. He was able to follow the objects, pupillary light reactions were normal, orthophoric in primary position with corneal light re... | TROPICAMIDE | DrugsGivenReaction | CC BY-NC-SA | 34667937 | 19,930,488 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaphylactic shock'. | Tropicamide and anaphylaxis: A case report.
A 6-month-old boy was brought to the ophthalmology outpatient clinic of our hospital by his parents with the suspicion of esotropia of his left eye. He was able to follow the objects, pupillary light reactions were normal, orthophoric in primary position with corneal light re... | TROPICAMIDE | DrugsGivenReaction | CC BY-NC-SA | 34667937 | 19,944,051 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Circulatory collapse'. | Tropicamide and anaphylaxis: A case report.
A 6-month-old boy was brought to the ophthalmology outpatient clinic of our hospital by his parents with the suspicion of esotropia of his left eye. He was able to follow the objects, pupillary light reactions were normal, orthophoric in primary position with corneal light re... | TROPICAMIDE | DrugsGivenReaction | CC BY-NC-SA | 34667937 | 19,930,488 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Tropicamide and anaphylaxis: A case report.
A 6-month-old boy was brought to the ophthalmology outpatient clinic of our hospital by his parents with the suspicion of esotropia of his left eye. He was able to follow the objects, pupillary light reactions were normal, orthophoric in primary position with corneal light re... | TROPICAMIDE | DrugsGivenReaction | CC BY-NC-SA | 34667937 | 19,930,488 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | Tropicamide and anaphylaxis: A case report.
A 6-month-old boy was brought to the ophthalmology outpatient clinic of our hospital by his parents with the suspicion of esotropia of his left eye. He was able to follow the objects, pupillary light reactions were normal, orthophoric in primary position with corneal light re... | TROPICAMIDE | DrugsGivenReaction | CC BY-NC-SA | 34667937 | 19,930,488 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Wrong technique in product usage process'. | Tropicamide and anaphylaxis: A case report.
A 6-month-old boy was brought to the ophthalmology outpatient clinic of our hospital by his parents with the suspicion of esotropia of his left eye. He was able to follow the objects, pupillary light reactions were normal, orthophoric in primary position with corneal light re... | TROPICAMIDE | DrugsGivenReaction | CC BY-NC-SA | 34667937 | 19,944,051 | 2021 |
What was the administration route of drug 'TROPICAMIDE'? | Tropicamide and anaphylaxis: A case report.
A 6-month-old boy was brought to the ophthalmology outpatient clinic of our hospital by his parents with the suspicion of esotropia of his left eye. He was able to follow the objects, pupillary light reactions were normal, orthophoric in primary position with corneal light re... | Ophthalmic | DrugAdministrationRoute | CC BY-NC-SA | 34667937 | 19,930,488 | 2021 |
What was the outcome of reaction 'Anaphylactic reaction'? | Tropicamide and anaphylaxis: A case report.
A 6-month-old boy was brought to the ophthalmology outpatient clinic of our hospital by his parents with the suspicion of esotropia of his left eye. He was able to follow the objects, pupillary light reactions were normal, orthophoric in primary position with corneal light re... | Recovered | ReactionOutcome | CC BY-NC-SA | 34667937 | 19,930,488 | 2021 |
What was the outcome of reaction 'Anaphylactic shock'? | Tropicamide and anaphylaxis: A case report.
A 6-month-old boy was brought to the ophthalmology outpatient clinic of our hospital by his parents with the suspicion of esotropia of his left eye. He was able to follow the objects, pupillary light reactions were normal, orthophoric in primary position with corneal light re... | Recovered | ReactionOutcome | CC BY-NC-SA | 34667937 | 19,944,051 | 2021 |
What was the outcome of reaction 'Circulatory collapse'? | Tropicamide and anaphylaxis: A case report.
A 6-month-old boy was brought to the ophthalmology outpatient clinic of our hospital by his parents with the suspicion of esotropia of his left eye. He was able to follow the objects, pupillary light reactions were normal, orthophoric in primary position with corneal light re... | Recovered | ReactionOutcome | CC BY-NC-SA | 34667937 | 19,930,488 | 2021 |
What was the outcome of reaction 'Respiratory failure'? | Tropicamide and anaphylaxis: A case report.
A 6-month-old boy was brought to the ophthalmology outpatient clinic of our hospital by his parents with the suspicion of esotropia of his left eye. He was able to follow the objects, pupillary light reactions were normal, orthophoric in primary position with corneal light re... | Recovered | ReactionOutcome | CC BY-NC-SA | 34667937 | 19,930,488 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atypical femur fracture'. | Fracture Risk Following an Atypical Femoral Fracture.
Atypical femoral fractures (AFFs) occurring during the course of osteoporosis treatment usually lead to discontinuation of anti-resorptive (AR) drugs. However, the risk of fracture after an AFF is unknown. We conducted a follow-up study of patients with AFF matched ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34668223 | 20,521,477 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foot fracture'. | Fracture Risk Following an Atypical Femoral Fracture.
Atypical femoral fractures (AFFs) occurring during the course of osteoporosis treatment usually lead to discontinuation of anti-resorptive (AR) drugs. However, the risk of fracture after an AFF is unknown. We conducted a follow-up study of patients with AFF matched ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34668223 | 20,521,477 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Forearm fracture'. | Fracture Risk Following an Atypical Femoral Fracture.
Atypical femoral fractures (AFFs) occurring during the course of osteoporosis treatment usually lead to discontinuation of anti-resorptive (AR) drugs. However, the risk of fracture after an AFF is unknown. We conducted a follow-up study of patients with AFF matched ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34668223 | 20,521,477 | 2021-10-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fractured sacrum'. | Fracture Risk Following an Atypical Femoral Fracture.
Atypical femoral fractures (AFFs) occurring during the course of osteoporosis treatment usually lead to discontinuation of anti-resorptive (AR) drugs. However, the risk of fracture after an AFF is unknown. We conducted a follow-up study of patients with AFF matched ... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34668223 | 20,521,477 | 2021-10-20 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.